Skip to main content

Global Targeted Cancer Therapies Market Growth Accelerated by Increasing Application of Targeted Cancer Therapies

Targeted Cancer Therapies Market

Targeted cancer therapies provide therapeutic options to patients suffering from cancer. These therapies specifically target molecular changes in cancer cells that help them grow, divide, and spread. They work by targeting specific vulnerabilities within tumor cells. Some of the key targeted cancer therapies include monoclonal antibodies, tyrosine kinase inhibitors, and agents targeting programmed cell death protein 1 and its ligand. The global Targeted Cancer Therapies Market is estimated to be valued at US$ 1603.7 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing application of targeted cancer therapies across different cancer types is expected to drive the market growth over the forecast period. Unlike traditional chemotherapy, targeted cancer therapies are designed to interfere with specific molecular changes that allow cancer to grow. This improves the efficacy of treatment and also reduces side effects associated with non-targeted chemotherapy. With advancements in understanding of cancer biology, more molecular targets are being identified which can be blocked by targeted therapies. This is further increasing the application of targeted therapies in treatment of cancers like lung cancer, breast cancer, prostate cancer and others. The development of effective targeted therapies designed for specific cancer mutations will remain an area of active research.

Segment Analysis

Targeted cancer therapies market is dominated by monoclonal antibodies sub segment. Monoclonal antibodies accounted for over 45% of the total targeted cancer therapies market in 2023. Monoclonal antibodies are specific immune proteins designed to recognize and attach to cancer cells. They can be designed to attack cancer cells more precisely than chemotherapy or regular antibodies. Their specificity helps minimize damage to healthy tissues. This make monoclonal antibodies an attractive and dominating treatment options for targeted cancer therapies.

Key Takeaways

The Global Targeted Cancer Therapies Market Size is expected to witness high growth over the forecast period of 2023 to 2030. Regional analysis related content comprises Asia Pacific is expected to be the fastest growing region in the targeted cancer therapies market. Increasing prevalence of cancer, rising healthcare spending, growing awareness about cancer treatment are some key factors driving the growth of targeted cancer therapies market in Asia Pacific region.

Key players operating in the targeted cancer therapies market are Amgen Inc., AstraZeneca PLC, Bayer AG, Johnson and Johnson and Merck & Co. Inc. These companies accounted for over 60% share of the global targeted cancer therapies market in 2023.

Explore more information on this topic, Please visit -

https://www.insightprobing.com/targeted-cancer-therapies-market-share-and-demand-analysis/

Labels:

Comments

Post a Comment

Popular posts from this blog

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...
Post a Comment
Read more

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...
Post a Comment
Read more

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...
Post a Comment
Read more